Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 25, 2025
The janus-faced effect of PD1 signaling on bone: do sex and age matter?
Sonia Vallet
Expert Opinion on Biological Therapy
|
June 18, 2013
New insights, recent advances, and current challenges in the biological treatment of multiple myeloma
Sonia Vallet, Klaus Podar
Current Opinion in Molecular Therapeutics
|
October 2, 2010
Sotatercept, a soluble activin receptor type 2A IgG-Fc fusion protein for the treatment of anemia and bone loss
Noopur Raje, Sonia Vallet
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society
|
December 6, 2011
Bone anabolic agents for the treatment of multiple myeloma
Sonia Vallet, Noopur Raje
Expert Opinion on Therapeutic Targets
|
May 26, 2011
CCR1 as a target for multiple myeloma
Sonia Vallet, Kenneth C Anderson
Cancer Journal (Sudbury, Mass.)
|
December 17, 2009
Future novel single agent and combination therapies
Diana Cirstea, Sonia Vallet, Noopur Raje
Expert Opinion on Biological Therapy
|
September 1, 2017
Adoptive cell therapy in multiple Myeloma
Sonia Vallet, Martin Pecherstorfer, Klaus Podar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2010
Novel bone-targeted strategies in oncology
Sonia Vallet, Matthew R Smith, Noopur Raje
Cancers
|
October 13, 2021
Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma
Samantha Pozzi, Alessia Bari, Martin Pecherstorfer, et al.
Expert Opinion on Emerging Drugs
|
July 23, 2019
Emerging protein kinase inhibitors for the treatment of multiple myeloma
Judith Lind, Felix Czernilofsky, Sonia Vallet, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 25, 2025
The janus-faced effect of PD1 signaling on bone: do sex and age matter?
Sonia Vallet
Expert Opinion on Biological Therapy
|
June 18, 2013
New insights, recent advances, and current challenges in the biological treatment of multiple myeloma
Sonia Vallet, Klaus Podar
Current Opinion in Molecular Therapeutics
|
October 2, 2010
Sotatercept, a soluble activin receptor type 2A IgG-Fc fusion protein for the treatment of anemia and bone loss
Noopur Raje, Sonia Vallet
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society
|
December 6, 2011
Bone anabolic agents for the treatment of multiple myeloma
Sonia Vallet, Noopur Raje
Expert Opinion on Therapeutic Targets
|
May 26, 2011
CCR1 as a target for multiple myeloma
Sonia Vallet, Kenneth C Anderson
Cancer Journal (Sudbury, Mass.)
|
December 17, 2009
Future novel single agent and combination therapies
Diana Cirstea, Sonia Vallet, Noopur Raje
Expert Opinion on Biological Therapy
|
September 1, 2017
Adoptive cell therapy in multiple Myeloma
Sonia Vallet, Martin Pecherstorfer, Klaus Podar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2010
Novel bone-targeted strategies in oncology
Sonia Vallet, Matthew R Smith, Noopur Raje
Cancers
|
October 13, 2021
Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma
Samantha Pozzi, Alessia Bari, Martin Pecherstorfer, et al.
Expert Opinion on Emerging Drugs
|
July 23, 2019
Emerging protein kinase inhibitors for the treatment of multiple myeloma
Judith Lind, Felix Czernilofsky, Sonia Vallet, et al.
Page
of 8